Growth Metrics

IGC Pharma (IGC) Change in Inventory (2016 - 2025)

IGC Pharma has reported Change in Inventory over the past 16 years, most recently at -$6000.0 for Q3 2025.

  • Quarterly Change in Inventory changed N/A to -$6000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$167000.0 through Sep 2025, up 83.68% year-over-year, with the annual reading at -$180000.0 for FY2025, 82.14% up from the prior year.
  • Change in Inventory was -$6000.0 for Q3 2025 at IGC Pharma, up from -$11000.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $322000.0 in Q1 2021 and troughed at -$1.9 million in Q1 2022.
  • The 5-year median for Change in Inventory is -$8000.0 (2023), against an average of -$206111.1.
  • The largest YoY upside for Change in Inventory was 3800.0% in 2022 against a maximum downside of 683.54% in 2022.
  • A 5-year view of Change in Inventory shows it stood at -$71000.0 in 2021, then skyrocketed by 97.18% to -$2000.0 in 2022, then soared by 1250.0% to $23000.0 in 2023, then crashed by 434.78% to -$77000.0 in 2024, then soared by 92.21% to -$6000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Change in Inventory are -$6000.0 (Q3 2025), -$11000.0 (Q2 2025), and -$73000.0 (Q1 2025).